I wish the world had more Rod Serling Twilight Zone bloopers

We’re excited to share that David R. Epstein has joined our Board of Directors. His wealth of knowledge from years of biopharma experience will be of great support as we seek new and innovative ways to partner with biopharma. Learn more: tempus.co/48qMYBT

Even at a higher threshold, initial evidence indicates that 25(OH)D levels below 75 nmol/L, reflecting vitamin D insufficiency, is associated with more aggressive behavior, particularly for reactive as opposed to proactive aggression (36).Jun 21, 2023. ncbi.nlm.nih.gov/pmc/articles/P…

Bryan Johnson is spending $2,000,000/year to live until 120. So I spent a full day researching his entire longevity blueprint. Here’s a full breakdown of his routine & how anyone can use it: (without spending $2M/year)

Advanced Explanation Of Manifestation

The Space Omics and Medical Atlas is the largest collection yet of health data gathered from astronauts and other civilians in space. Chris Mason spoke with STAT's Nicholas St. Fleur about the release. trib.al/IawDYpE

Sun exposure, sunscreens, acne, skin cancer, rosacea, offsetting skin aging, phototherapy, nutrition, psoriasis, peptides, collagen supplementation and other aspects of skin health and appearance on the Huberman Lab podcast out now. hubermanlab.com/episode/how-to…

Big Nature paper this week on improved lifespan (in mice!) using an antibody to block IL11 Old mice without IL11 even look healthier 🧵

Landmark speech in UK’s House of Lords yesterday: “By becoming the first country to treat ageing as a medical condition, we can chart a course for more effective interventions and improved health outcomes.” Transcript below Evgeny Lebedev tinyurl.com/uu26htsv

Genes and #regeneration: Extending lifespan through #genetransfer Transferring regeneration-associated genes from simple organisms to complex animals could be a way to combat aging and enhance #longevity. #innovation #genes longevity.technology/news/genes-and…

How do you rate my chances at breakdancing in the next Olympics?

Join us for an upcoming webinar on Monday, July 14. Hear from Arun Krishna and Ahmed ElNawawi, alongside Ryan Fukushima, as they unveil innovative strategies to optimize market understanding of therapy trends and adherence to guideline driven care in the dynamic field of

With olivia, we’re putting the power of AI directly into patients’ hands and giving them the tools and insights they deserve to truly understand their health and actively participate in their care. olivia enables patients to carry their complete healthcare journey in their

We are excited to share that we have received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for our Tempus ECG-Low EF software, which uses AI to identify patients who may have a low left ventricular ejection fraction (LVEF).  This is our second FDA approved

Welcome Paige to Tempus.  Together, we're about to take a giant step forward in bringing AI to diagnostics as combined we have one of the largest libraries of digital pathology images connected to rich clinical and molecular insights in the world. Given our combined AI

Happy 10th birthday Tempus. What we’ve achieved in the past decade is extraordinary and wouldn’t have been possible without our team’s dedication to improving patients’ lives and tackling complex challenges. Despite our progress, I’m convinced our best days are ahead of us.

Join us on Monday, September 15 for a live webinar with Sanjay Juneja, M.D. Juneja and Debra Patt, MD PhD MBA. These industry experts will be discussing AI’s real-world oncology applications and how AI platforms integrated into EHRs are enabling more context-aware insights and

With just one click on Tempus Hub, Comprehensive Therapy Selection (CTS) makes it easy to get the right tests - DNA, RNA, IHCs, and more - tailored to each patient’s cancer diagnosis. Learn more: tempus.co/4mOrQgI

People can work surprisingly hard without burnout as long as they feel like they’re winning.

We are thrilled to announce that we have received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for our updated Tempus Pixel, an AI-powered cardiac imaging platform. This update allows the generation of T1 and T2 inline maps, further enhancing the device’s